Funding for this research was provided by:
National Natural Science Foundation of China (H1609-81172102)
National Key Research and Development Program of China Stem Cell and Translational Research (2016YFA0101501)
Received: 14 December 2019
Accepted: 20 October 2020
First Online: 4 November 2020
Ethics approval and consent to participate
: None of the cell lines used in the present study required ethics approval for their use.
: Not relevant.
: The authors declare that they have no competing interests.